Deepening crisis sends Valeant shares into a tailspin

By Poroma Pant Shares of Valeant Pharmaceuticals International Inc. went into freefall Tuesday after the embattled pharmaceutical company warned its investors of sharply curtailed earnings expectations and disclosed that it’s in danger of defaulting on some of its debt. In a conference call, analysts grilled Chief Executive Officer Mike Pearson with questions regarding his leadership […]